Armin Graber

Armin Graber, PhD habil., is a seasoned expert in translational medicine, biomarkers, and companion diagnostics, currently serving as Senior Vice President and Head of Translational Medicine, Biomarkers and CDx at BlossomHill Therapeutics since October 2023. Previously, Armin held senior leadership roles at Turning Point Therapeutics and Genoptix, where responsibilities included the development and implementation of biomarker strategies and diagnostic products. Armin's extensive experience also includes positions at Novartis Oncology, UMIT, and BG Medicine, focusing on bioinformatics, clinical research, and product development. Academic credentials include a Ph.D. in Biostatistics and Biomedical Informatics and a Privatdozent degree in Bioinformatics in Translational Medicine.